Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin

Arthritis Research and Therapy

Volumn 6, Issue 2, 2004, Pages

  Vossenaar, Erik R ^a   Després, Normand ^b   Lapointe, Elvy ^b   van der Heijden, Annemarie ^a   Lora, Maximillian ^b   Senshu, Tatsuo ^c   van Venrooij, Walther J ^a   Ménard, Henri A ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

anti Sa antibodies; anticitrullinated protein peptide antibodies; citrullinated vimentin; rheumatoid arthritis; Sa antigen

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; CITRULLINE; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; MEMBRANE ANTIGEN; RECOMBINANT PROTEIN; VIMENTIN;

ANTIBODY SPECIFICITY; ARTICLE; CHEMISTRY; CLINICAL TRIAL; HUMAN; IMMUNOLOGY; METABOLISM; MULTICENTER STUDY; PLACENTA; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY SPECIFICITY; ANTIGENS, SURFACE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CITRULLINE; HUMANS; PEPTIDES, CYCLIC; PLACENTA; RECOMBINANT PROTEINS; SYNOVIAL MEMBRANE; VIMENTIN;

EID: 1842619397     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1149     Document Type: Article

References (75)

1. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ: Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 2002, 4: 87-93. 10.1186/ar395. DOI: 10.1186/ar395
2. Steiner G, Smolen J: Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. 2002, Suppl 2: S1-S5. 10.1186/ar551. DOI: 10.1186/ar551
3. Mageed RA: The RF antigen. In Manual of Biological Markers of Disease. Edited by: van Venrooij WJ, Maini RN. 1996, Dordrecht, The Netherlands: Kluwer Academic Publishers, Section B1.1: 1-27.
4. Lisse JR: Does rheumatoid factor always mean arthritis?. Postgrad Med. 1993, 94: 133-134.
5. Palosuo T, Tilvis R, Strandberg T, Aho K: Filaggrin related antibodies among the aged. Ann Rheum Dis. 2003, 62: 261-263. 10.1136/ard.62.3.261. DOI: 10.1136/ard.62.3.261
6. Despres N, Boire G, Lopez LF, Menard HA: The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol. 1994, 21: 1027-1033.
7. Menard HA, Lapointe E, Rochdi MD, Zhou ZJ: Insights into rheumatoid arthritis derived from the Sa immune system. Arthritis Res. 2000, 2: 429-432. 10.1186/ar122. DOI: 10.1186/ar122
8. Vossenaar ER, van Venrooij WJ: Anti-CCP antibodies, a specific marker for (early) rheumatoid arthritis. Clin Applied Immunol Rev.
9. Vossenaar ER, Zendman AJW, van Venrooij WJ, Pruijn G: PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease. Bioessays. 2003, 25: 1106-1118. 10.1002/bies.10357. DOI: 10.1002/bies.10357
10. Rantapää-Dahlqvist, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2741-2749. 10.1002/art.11223. DOI: 10.1002/art.11223
11. Nielen MMJ, Van Schaardenburg D, Reesink HWR, van de Stadt RJ, vander HorstBruinsma I, de Koning MHM, Habibuw MR, Vandenbroucke JP, Dijkmans BA: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum.
12. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, van de Putte LB, van Rijswijk MH, van Venrooij WJ, van Riel PL: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1831-1835. 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6. DOI: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6
13. Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzockova S: Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 2003, 62: 427-430. 10.1136/ard.62.5.427. DOI: 10.1136/ard.62.5.427
14. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B: Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis. 2003, 62: 120-126. 10.1136/ard.62.2.120. DOI: 10.1136/ard.62.2.120
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. DOI: 10.1002/art.1780310302
16. Senshu T, Sato T, Inoue T, Akiyama K, Asaga H: Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem. 1992, 203: 94-100. 10.1016/0003-2697(92)90047-B. DOI: 10.1016/0003-2697(92)90047-B
17. Senshu T, Akiyama K, Kan S, Asaga H, Ishigami A, Manabe M: Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues. J Invest Dermatol. 1995, 105: 163-169. 10.1111/1523-1747.ep12317070. DOI: 10.1111/1523-1747.ep12317070
18. Ramaekers F, Huysmans A, Schaart G, Moesker O, Vooijs P: Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res. 1987, 170: 235-249. 10.1016/0014-4827(87)90133-9. DOI: 10.1016/0014-4827(87)90133-9
19. Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, Benali K, Eliaou JF, Kahn MF, Sany J, Meyer O: Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol. 1999, 26: 7-13.
20. Liang FT, Granstrom DE, Timoney JF, Shi YF: Micropreparative high resolution purification of proteins by a combination of sodium dodecyl sulfate-polyacrylamide gel electrophoresis, isoelectric focusing, and membrane blotting. Anal Biochem. 1997, 250: 61-65. 10.1006/abio.1997.2196. DOI: 10.1006/abio.1997.2196
21. Bouffard P, Gagnon C, Cloutier D, MacLean SJ, Souleimani A, Nallainathan D, Home WA, Pilon N, Gibson DM: Analysis of T cell receptor beta expression by isoelectric focusing following gene amplification and in vitro translation. J Immunol Methods. 1995, 187: 9-21. 10.1016/0022-1759(95)00161-3. DOI: 10.1016/0022-1759(95)00161-3
22. Brewer E, Henion J: Atmospheric pressure ionization LC/MS/MS techniques for drug disposition studies. J Pharm Sci. 1998, 87: 395-402. 10.1021/js9701059. DOI: 10.1021/js9701059
23. Banks-Schlegel SP, Harris CC: Tissue-specific expression of keratin proteins in human esophageal and epidermal epithelium and their cultured keratinocytes. Exp Cell Res. 1983, 146: 271-280. 10.1016/0014-4827(83)90129-5. DOI: 10.1016/0014-4827(83)90129-5
24. Habets WJ, Hoet MH, de Jong BA, Van der KA, van Venrooij WJ: Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. J Immunol. 1989, 143: 2560-2566.
25. Inagaki M, Nishi Y, Nishizawa K, Matsuyama M, Sato C: Site-specific phosphorylation induces disassembly of vimentin filaments in vitro. Nature. 1987, 328: 649-652. 10.1038/328649a0. DOI: 10.1038/328649a0
26. Asaga H, Yamada M, Senshu T: Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun. 1998, 243: 641-646. 10.1006/bbrc.1998.8148. DOI: 10.1006/bbrc.1998.8148
27. Asaga H, Senshu T: Combined biochemical and immunocytochemical analyses of postmortem protein deimination in the rat spinal cord. Cell Biol Int. 1993, 17: 525-532. 10.1006/cbir.1993.1094. DOI: 10.1006/cbir.1993.1094
28. Vossenaar ER, Radstake TR, van der Heijden A, Van Mansum WAM, Dieteren C, de Rooij DJ, Barrera P, Zendman AJW, van Venrooij WJ: Expression and activity of citrullinating PAD enzymes in monocytes and macrophages. Ann Rheum Dis.
29. Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM: Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem. 1996, 271: 30709-30716. 10.1074/jbc.271.48.30709. DOI: 10.1074/jbc.271.48.30709
30. Senshu T, Kan S, Ogawa H, Manabe M, Asaga H: Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys Res Commun. 1996, 225: 712-719. 10.1006/bbrc.1996.1240. DOI: 10.1006/bbrc.1996.1240
31. Senshu T, Akiyama K, Nomura K: Identification of citrulline residues in the V subdomains of keratin K1 derived from the cornified layer of newborn mouse epidermis. Exp Dermatol. 1999, 8: 392-401. 10.1159/000014615. DOI: 10.1111/j.1600-0625.1999.tb00388.x
32. Ishida-Yamamoto A, Senshu T, Eady RA, Takahashi H, Shimizu H, Akiyama M, Iizuka H: Sequential reorganization of cornified cell keratin filaments involving filaggrin-mediated compaction and keratin 1 deimination. J Invest Dermatol. 2002, 118: 282-287. 10.1046/j.0022-202x.2001.01671.x. DOI: 10.1046/j.0022-202x.2001.01671.x
33. Saulot V, Yon G, Vittecoq O, Charlionnet G, Manchour N, Lange C, Marvin L, Gilbert D, Le Loet X: Sa, alpha-enolase and rheumatoid arthritis [abstract]. Arthritis Rheum. 2000, 43 (Suppl): S68-
34. Despres N, Talbot G, Plouffe B, Boire G, Menard HA: Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest. 1995, 95: 1891-1896. DOI: 10.1172/JCI117870
35. Saulot V, Vittecoq O, Charlionet R, Fardellone P, Lange C, Marvin L, Machour N, Le LX, Gilbert D, Tron F: Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 2002, 46: 1196-1201. 10.1002/art.10252. DOI: 10.1002/art.10252
36. Menard HA, El-Amine M: The calpain-calpastatin system in rheumatoid arthritis. Immunol Today. 1996, 17: 545-547. 10.1016/S0167-5699(96)30064-9. DOI: 10.1016/S0167-5699(96)30064-9
37. Escalona M, Lopez LF, Rodriguez-Mahou M, Gonzalez C, Monteagudo I, Del Castillo R, Caro N, Gonzalez-Montagut C, Cebrian L, Carreno L: Sa antigen is an apolipoprotein-a-1-binding protein [abstract]. Arthritis Rheum. 2001, 44 (Suppl): S304-
38. Escalona M, Lopez-Longo FJ, Gonzalez CM, Monteagudo I, Rodriguez-Mahou M, Grau R, Carreno L: Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies. J Rheumatol. 2002, 29: 2053-2060.
39. Kurki P, Helve T, Virtanen I: Antibodies to cytoplasmic intermediate filaments in rheumatic diseases. J Rheumatol. 1983, 10: 558-562.
40. Senecal JL, Rothfield NF, Oliver JM: Immunoglobulin M autoantibody to vimentin intermediate filaments. J Clin Invest. 1982, 69: 716-721. DOI: 10.1172/JCI110500
41. Brown C, Pedersen J, Underwood JR, Gust I, Toh BH: Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin. J Clin Lab Immunol. 1986, 19: 1-4.
42. Yang Y, Fujita J, Bandoh S, Ohtsuki Y, Yamadori I, Yoshinouchi T, Ishida T: Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. Clin Exp Immunol. 2002, 128: 169-174. 10.1046/j.1365-2249.2002.01811.x. DOI: 10.1046/j.1365-2249.2002.01811.x
43. Yasuda M, Nobunaga M: Antibodies to cytoskeletal systems in normal human serum. Fukuoka Igaku Zasshi. 1990, 81: 323-330.
44. Doyle HA, Mamula MJ: Posttranslational protein modifications: new flavors in the menu of autoantigens. Curr Opin Rheumatol. 2002, 14: 244-249. 10.1097/00002281-200205000-00009. DOI: 10.1097/00002281-200205000-00009
45. Utz PJ, Gensler TJ, Anderson P: Death, autoantigen modifications, and tolerance. Arthritis Res. 2000, 2: 101-114. 10.1186/ar75. DOI: 10.1186/ar75
46. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 1999, 190: 815-826. 10.1084/jem.190.6.815. DOI: 10.1084/jem.190.6.815
47. Piacentini M, Colizzi V: Tissue transglutaminase: apoptosis versus autoimmunity. Immunol Today. 1999, 20: 130-134. 10.1016/S0167-5699(98)01416-9. DOI: 10.1016/S0167-5699(98)01416-9
48. Utz PJ, Hottelet M, Schur PH, Anderson P: Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med. 1997, 185: 843-854. 10.1084/jem.185.5.843. DOI: 10.1084/jem.185.5.843
49. Zampieri S, Degen W, Ghirardello A, Doria A, van Venrooij WJ: Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus. Ann Rheum Dis. 2001, 60: 72-76. 10.1136/ard.60.1.72. DOI: 10.1136/ard.60.1.72
50. Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C: Ca(2+)-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem. 1989, 264: 18119-18127.
51. Rodenburg RJ, Raats JM, Pruijn GJ, van Venrooij WJ: Cell death: a trigger of autoimmunity?. Bioessays. 2000, 22: 627-636. 10.1002/1521-1878(200007)22:7<627::AID-BIES5>3.3.CO;2-B. DOI: 10.1002/1521-1878(200007)22:7<627::AID-BIES5>3.0.CO;2-K
52. Matzinger P: The danger model: a renewed sense of self. Science. 2002, 296: 301-305. 10.1126/science.1071059. DOI: 10.1126/science.1071059
53. Eriksson JE, Opal P, Goldman RD: Intermediate filament dynamics. Curr Opin Cell Biol. 1992, 4: 99-104. 10.1016/0955-0674(92)90065-K. DOI: 10.1016/0955-0674(92)90065-K
54. Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem. 1994, 63: 345-382. DOI: 10.1146/annurev.bi.63.070194.002021
55. Strelkov SV, Herrmann H, Aebi U: Molecular architecture of intermediate filaments. Bioessays. 2003, 25: 243-251. 10.1002/bies.10246. DOI: 10.1002/bies.10246
56. Bruneel A, Labas V, Mailloux A, Sharma S, Vinh J, Vaubourdolle M, Baudin B: Proteomic study of human umbilical vein endothelial cells in culture. Proteomics. 2003, 3: 714-723. 10.1002/pmic.200300409. DOI: 10.1002/pmic.200300409
57. Visser H, Le Cessie S, Vos K, Breedveld FC, Hazes JM: How to diagnose rheumatoid arthritis early? A prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002, 46: 357-365. 10.1002/art.10117. DOI: 10.1002/art.10117
58. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Menard HA, Zhou ZJ, Palosuo T, van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HRJ, El-Gabalawy HS: Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2000, 2: 236-243. 10.1186/ar93. DOI: 10.1186/ar93
59. Berglin E, Padyukov L, Hallmans G, van Venrooij WJ, Klareskog L, Rantapää-Dahlquist S: Presence of the shared epitope genes increase the predictive value of antibodies against cyclic citrullinated peptide (CCP) for rheumatoid arthritis [abstract]. Arthritis Rheum. 2003, 48 (Suppl): S678-
60. Vincent C, Simon M, Sebbag M, Girbal NE, Durieux JJ, Cantagrel A, Fournie B, Mazieres B, Serre G: Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol. 1998, 25: 838-846.
61. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, Heikkila R, Nykanen M, von Essen R: Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol. 1998, 115: 294-302. 10.1159/000069460. DOI: 10.1159/000069460
62. Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournie B, Cantagrel A, Jolivet M, Serre G: Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis. 2001, 60: 882-887.
63. Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Nyonsenga T, Gingras M, Daniel C, Beauchemin J, Menard HA: Anti-Sa/citrullinated vimentin antibodies (anti-Sa Abs), anti-cyclic citrullinated peptide (anti-CCP) Abs and IgM rheumatois factor (RF) as prognostic markers of disease severity in early polyarthritis (EPA) patients [abstract]. Arthritis Rheum. 2003, 48 (Suppl): S666-
64. Nienhuis RLF, Mandema EA: A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis. 1964, 23: 302-305. DOI: 10.1136/ard.23.4.302
65. Young BJ, Mallya RK, Leslie RD, Clark CJ, Hamblin TJ: Anti-keratin antibodies in rheumatoid arthritis. Br Med J. 1979, 2: 97-99. DOI: 10.1136/bmj.2.6182.97
66. Simon M, Girbal E, Sebbag M, Gomes-Daudrix V, Vincent C, Salama, Serre G: The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest. 1993, 92: 1387-1393. DOI: 10.1172/JCI116713
67. Sebbag M, Simon M, Vincent C, Masson BC, Girbal E, Durieux JJ, Serre G: The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1995, 95: 2672-2679. DOI: 10.1172/JCI117969
68. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998, 101: 273-281. DOI: 10.1172/JCI1316
69. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000, 43: 155-163. 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3. DOI: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3
70. Lapointe E, Déry U, Vaillancourt F, Menard HA, Senshu T: Rheumatoid sera recognize all citrullinated proteins [abstract]. Arthritis Rheum. 1999, 42 (Suppl): S86-
71. Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letourneur O, Rolland D, Fournie B, Cantagrel A, Jolivet M, Serre G: Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum. 2002, 46: 2051-2058. 10.1002/art.10436. DOI: 10.1002/art.10436
72. Nogueira L, Chapuy-Ragaud S, Constantin A, Clavel C, Sebbag M, Cantagrel A, Vincent C, Serre G: Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for early rheumatoid arthritis [abstract]. Arthritis Res Ther. 2003, Suppl 1: 18-10.1186/ar648. DOI: 10.1186/ar648
73. van Venrooij WJ, Hazes JM, Visser H: Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med. 2002, 60: 383-388.
74. Vasishta A: Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab. 2002, 21: 34-36.
75. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E: Cutting Edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003, 171: 538-541. DOI: 10.4049/jimmunol.171.2.538